Author:
Toledano Alain,Luporsi Elisabeth,Morere Jean François,Scotté Florian,Laribi Kamel,Barrière Jérôme,Huot-Marchand Philippe,Duvillié Ladan,Concas Victor Hugo,Bugat Roland
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Aapro M, Osterborg A, Gascon P, Ludwig H, Beguin Y (2012) Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of intravenous iron. Ann Oncol 23:1954–1962
2. Aapro MS, Link H (2008) September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents. Oncologist 13(Suppl 3):33–36
3. National Comprehensive Cancer Network Inc (2014) NCCN Practice Guidelines in Oncology; Cancer and Chemotherapy-Induced Anemia - Version 2.2015. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#supportive . Accessed 28 October 2014
4. Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, Spivak JL, Bennett CL, Bohlius J, Evanchuk D, Goode MJ, Jakubowski AA, Regan DH, Somerfield MR (2010) American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. Blood 116:4045–4059
5. Athibovonsuk P, Manchana T, Sirisabya N (2013) Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy. Gynecol Oncol 131:679–682
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献